Search results
Can Moderna Achieve Its Most Ambitious Goal Yet?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) and ambition seem to go hand and hand. The company doesn't fear taking on challenges, as it demonstrated during the earliest days...
Can This AI Deal With IBM Be a Game-Changer for Moderna?
Motley Fool· 1 year agoYou may not automatically think of artificial intelligence (AI) or quantum computing when you think...
3 Reasons Why Moderna Stock Is so Cheap Right Now
Motley Fool· 2 years agoModerna's (NASDAQ: MRNA) stock is in poor shape. Unfortunately, when investors take a closer look at why Moderna's stock is so inexpensive, they probably...
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
Motley Fool· 7 months agoVaccine leaders Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are making gains in this competition,...
This High-Growth Company Is Expanding. Time to Buy the Stock?
Motley Fool· 1 year agoModerna's (NASDAQ: MRNA) reliance on its COVID-19 vaccine has worried some investors. The vaccine --...
Research not funded, demoted and then let go. She just won the Nobel prize
Deseret News via Yahoo News· 7 months agoHungarian-American biochemist Katalin Kariko speaks at the University of Pennsylvania on Monday,...
Better Healthcare AI Stock: Moderna vs. Doximity
Motley Fool· 11 months agoThe AI in healthcare market is expected to top $100 billion by the end of the decade, and some companies are already leveraging this technology to...
Surprise! This Potential AI Winner Isn't a Tech Stock.
Motley Fool· 8 months agoIn Boston Consulting Group's list of top AI innovators, Moderna and Tesla are the only nontech...
Newer coronavirus subvariants ticking up in California amid concerns of winter wave
LA Times via Yahoo News· 2 years agoCalifornia is closely watching a rise in new subvariants, as L.A. County and San Francisco Bay Area...
What’s in the Novavax Vaccine? Experts Break It All Down
Prevention via Yahoo News· 2 years agoThe Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for use in the U.S....